CRIS Current Research Information System

BOCHICCHIO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.094
AS - Asia 1.698
EU - Europa 1.672
AF - Africa 123
SA - Sud America 106
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.070
SG - Singapore 558
CN - Cina 540
GB - Regno Unito 396
IT - Italia 306
SE - Svezia 248
VN - Vietnam 213
DE - Germania 204
HK - Hong Kong 134
NL - Olanda 108
IN - India 98
RU - Federazione Russa 91
BR - Brasile 75
FR - Francia 66
IE - Irlanda 61
KR - Corea 58
JO - Giordania 37
TG - Togo 34
EE - Estonia 32
ZA - Sudafrica 31
FI - Finlandia 26
BG - Bulgaria 25
NG - Nigeria 23
UA - Ucraina 23
CH - Svizzera 22
CI - Costa d'Avorio 19
BE - Belgio 15
CA - Canada 15
JP - Giappone 14
AT - Austria 13
ES - Italia 13
AR - Argentina 12
SC - Seychelles 12
ID - Indonesia 11
EC - Ecuador 9
IR - Iran 7
MX - Messico 7
PL - Polonia 7
BD - Bangladesh 6
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
PY - Paraguay 4
CL - Cile 3
MK - Macedonia 3
RO - Romania 3
CZ - Repubblica Ceca 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
IQ - Iraq 2
LB - Libano 2
LT - Lituania 2
PT - Portogallo 2
VE - Venezuela 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
GM - Gambi 1
IL - Israele 1
KG - Kirghizistan 1
MA - Marocco 1
MY - Malesia 1
PK - Pakistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.699
Salva come PNG Salva come JPEG
Città #
Singapore 372
Southend 362
Chandler 251
Ashburn 233
Fairfield 182
Hong Kong 131
Hefei 122
Dong Ket 120
Ann Arbor 111
Houston 100
Beijing 87
Wilmington 81
Seattle 79
Princeton 78
Woodbridge 78
Cambridge 70
Dublin 61
Boardman 60
New York 55
Seoul 55
Santa Clara 53
Bologna 49
Nanjing 48
Amman 37
Lomé 34
Westminster 33
Padova 31
Dallas 29
Ho Chi Minh City 25
Sofia 25
Medford 24
Munich 23
Buffalo 22
Hanoi 22
Los Angeles 22
Milan 22
Abeokuta 21
Bern 20
Abidjan 19
Jinan 19
Shenyang 18
Berlin 16
Bremen 16
Brussels 15
Hebei 15
Redondo Beach 14
Helsinki 13
Frankfurt am Main 12
Saint Petersburg 12
Bengaluru 11
Redmond 11
Redwood City 10
Rome 10
Tokyo 10
Turin 10
Jiaxing 9
Nanchang 9
Norwalk 9
Tianjin 9
Guangzhou 8
Jakarta 8
London 8
Nuremberg 8
San Diego 8
São Paulo 8
Vienna 8
Biên Hòa 7
Changsha 7
Salamanca 7
Turku 7
Castel Maggiore 6
Falkenstein 6
Florence 6
Monza 6
Shanghai 6
Shijiazhuang 6
Torino 6
Bühl 5
Chicago 5
Dearborn 5
Granarolo dell'Emilia e Viadagola 5
Hangzhou 5
Lappeenranta 5
Montreal 5
Phoenix 5
Stockholm 5
Toronto 5
Verona 5
Brasília 4
Falls Church 4
Farra d'Isonzo 4
Genoa 4
Haikou 4
Haiphong 4
Hyderabad 4
Mountain View 4
Paris 4
Tongling 4
Warsaw 4
Wuhan 4
Totale 3.724
Salva come PNG Salva come JPEG
Nome #
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 218
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 197
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 197
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 194
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: Molecular cytogenetic characterization and influence on TKIs therapy 191
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 176
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 153
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 149
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia 148
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience 146
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 139
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications 137
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease 134
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 134
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions 131
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia 131
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 131
Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected 131
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study 129
High Sensitivity Mutation Monitoring and Clonal Analysis by Ultra-Deep Amplicon Sequencing Uncover the Complexity of BCR-ABL Mutation Status in Philadelphia+ Patients Treated with Tyrosine Kinase Inhibitors 128
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients 128
High frequency of small insertions and deletions in the BCR-ABL Kinase Domain revealed by ultra-deep sequencing 128
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations 127
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 127
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain. 127
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment 124
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications 123
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 122
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 121
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients 121
High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors 118
Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience 118
Ultra-Deep Amplicon Sequencing Using Roche 454 Technology Allows High Sensitivity Bcr-Abl Kinase Domain Mutation Screening and Anticipates Emerging Mutations Leading to Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients 115
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 110
Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction 109
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 104
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 103
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. 102
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain 101
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain 100
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3‐mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real‐life setting 99
Differences among young adults, adults and elderly chronic myeloid leukemia patients 87
null 81
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells 75
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study 66
Totale 5.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021338 0 0 0 0 0 20 11 23 52 22 30 180
2021/2022750 43 11 53 77 72 41 16 42 45 71 136 143
2022/2023903 100 125 37 121 69 64 27 60 177 15 62 46
2023/2024290 7 42 21 30 20 72 11 18 23 8 18 20
2024/20251.005 39 132 74 75 103 40 99 30 18 135 44 216
2025/20261.210 219 232 243 176 276 64 0 0 0 0 0 0
Totale 5.830